Precision Neuroscience
Precision Neuroscience Raises $102M Series C | Brain-Computer Interface
Precision Neuroscience Closes $102M for BCI Development
Precision Neuroscience, developing minimally invasive brain-computer interface technology, has raised $102 million in Series C funding.
The round was led by B Capital with participation from Steadview Capital and Alumni Ventures.
Key Highlights
- Total funding to date: $155 million
- Minimally invasive neural implant approach
- Founded by Neuralink co-founder
Company Overview
Precision Neuroscience is developing minimally invasive brain-computer interface technology to restore function for patients with neurological conditions, competing with Neuralink in the emerging BCI market.
Company Info
Investors (3)
Share
Related Reports
Basecamp Research Raises $140M Series C for AI-Designed Medicines
Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.
Ema Raises $77M Series B to Expand Its Enterprise AI Employee Platform
Ema raised a $77 million Series B led by Creaegis, bringing total funding to $140 million as it scales AI agents across enterprise workflows.
Chamelio Raises $26M Series A for AI-Native Legal Operations
Chamelio raised a $26 million Series A led by Entrée Capital to replace legacy contract-management systems with agentic legal operations.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free